"It has been a wonderful experience and a great opportunity for me especially at this early stage in my scientific training."
The American Society of Haematology (ASH) conference this year was held in sunny San Diego, California. The conference w...
5 years ago
A new DNA marker may prove useful as a predictor of poor outcomes in multiple myeloma, US researchers have reported.
20% of multiple myeloma patients relapse or die within two years of diagnosis, and are designated ‘high-risk’. Scientists at Emory...
5 years ago
